Tony Edlin, MBA, CPC, is a seasoned market access professional with over 20 years of experience specializing in reimbursement strategies for high-cost biologic therapies in the oncology, hematology, neurology, and rare disease spaces. Currently serving as the Regional Reimbursement Director for Ipsen Biopharmaceuticals, Tony directs reimbursement strategies across a seven-state territory, focusing on injectable and infused therapies. Previously, Tony held positions at prominent companies such as Heron Therapeutics and Amgen, where they developed reimbursement strategies and engaged with payers to improve access to vital therapies. Tony's expertise includes coding, coverage, and payment advocacy, ensuring seamless operations for provider-administered drugs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices